Email this article Development of Immunoadsorbent for C5а Anaphylatoxin Elimination from Blood Plasma of Patients with Complement Hyperactivation-associated Pathologies
- Authors: Denisenko E..1, Zhakhov A..1, Gorbunov N..1, Trofimov A..1, Ischenko A..1
-
Affiliations:
- Issue: Vol 21, No 4 (2018)
- Pages: 657-659
- Section: SHORT COMMUNICATIONS
- Submitted: 22.10.2020
- Published: 15.10.2018
- URL: https://rusimmun.ru/jour/article/view/810
- DOI: https://doi.org/10.31857/S102872210002629-6
- ID: 810
Cite item
Full Text
Abstract
About the authors
E. . Denisenko
Author for correspondence.
Email: noemail@neicon.ru
Russian Federation
A. . Zhakhov
Email: noemail@neicon.ru
Russian Federation
N. . Gorbunov
Email: noemail@neicon.ru
Russian Federation
A. . Trofimov
Email: noemail@neicon.ru
Russian Federation
A. . Ischenko
Email: noemail@neicon.ru
Russian Federation
References
- Chunguang Yan, Hongwei Gao. New insights for C5a and C5a receptors in sepsis. Front Immunol., 2012, 5, 197.
- Aird W. C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood, 2003, 101, 3765–3777.
- Peter A. Ward Role of C5 Activation Products in Sepsis. The Scientifi c World Journal, 2010, 10, 2395–24022010.
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).